Post by PooDolla on Sept 24, 2015 12:04:02 GMT -7
Wall Street is already betting that a President Hillary Clinton may not be good for the red-hot biotech industry.
Biotech stocks tumbled on Monday after Clinton fired off a tweet about "price gouging" in biotech drugs.
Prices had skyrocketed overnight to $750 from just $13.50 each for a drug called Daraprim -- a 62-year-old drug used to treat a life-threatening parasitic infection. Clinton sent out a link to a New York Times article about it.
Clinton promised to unveil a plan on Tuesday to take on "outrageous" price increases like that one. Her campaign did not immediately respond to a request for comment on specifics.
Biotech stocks tumbled on Monday after Clinton fired off a tweet about "price gouging" in biotech drugs.
Prices had skyrocketed overnight to $750 from just $13.50 each for a drug called Daraprim -- a 62-year-old drug used to treat a life-threatening parasitic infection. Clinton sent out a link to a New York Times article about it.
Clinton promised to unveil a plan on Tuesday to take on "outrageous" price increases like that one. Her campaign did not immediately respond to a request for comment on specifics.